title: How should influenza be treated? Focus on antivirals.
authors.affiliation: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: GAvEssen@paladijnenweg.nl.
authors.forename: G Errit A
authors.initials: GE
authors.lastname: van Essen
authors.affiliation: Imperial College London, London, UK.
authors.forename: Peter
authors.initials: P
authors.lastname: Openshaw
authors.affiliation: University of Nottingham, Nottingham, UK.
authors.forename: Puja
authors.initials: P
authors.lastname: Myles
authors.affiliation: University of Michigan School of Public Health, Ann Arbor, MI, USA.
authors.forename: Arnold
authors.initials: A
authors.lastname: Monto
authors.affiliation: Erasmus MC, Rotterdam, The Netherlands.
authors.forename: Erhard
authors.initials: E
authors.lastname: van der Vries
mesh_terms: D000998:Antiviral Agents / Q000600:supply & distribution* / Q000627:therapeutic use*; D003226:Congresses as Topic; D005060:Europe; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D058873:Pandemics / Q000517:prevention & control
chemical_list: D000998:Antiviral Agents